Henry Schein Inc (HSIC)
Official siteHEALTHCARE • MEDICAL DISTRIBUTION • NASDAQ
Market Cap: $9.53B
Last updated: Nov 17, 2026 at 11:06 AM ET
Henry Schein Inc (HSIC) Stock Forecast
Analysts expect Henry Schein (HSIC) to earn $5.53 per share in the fiscal year ending Dec 31, 2026, on revenue of $13.84B. Of 16 analysts, 8 rate the stock Buy or Strong Buy, 7 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 11 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 16 ratings average 2.31, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 50% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 4 | 25.0% |
| Buy | 4 | 25.0% |
| Hold | 7 | 43.8% |
| Sell | 1 | 6.3% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 16
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 8.7% and revenue estimates rise 3.8%.
- Fiscal year ending Dec 31, 2026
- $5.53
- EPS consensus, revenue $13.84B
- Fiscal year ending Dec 31, 2027
- $6.01
- EPS consensus, revenue $14.37B
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $5.53 | $5.36 to $5.60 | 15 | $13.84B | $13.81B to $13.87B | 15 |
| Dec 31, 2027 | $6.01 | $5.88 to $6.18 | 16 | $14.37B | $14.18B to $14.51B | 15 |
Quarterly Estimates
The EPS consensus is $1.43 for both quarters below, ending Dec 31, 2026 and Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.43 | $1.35 to $1.49 | 19 | $3.62B | $3.44B to $3.75B | 17 |
| Mar 31, 2027 | $1.43 | $1.41 to $1.48 | 11 | $3.48B | $3.45B to $3.53B | 8 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 24 upward and 8 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 11 | 1 |
| Fiscal year ending Dec 31, 2027 | 9 | 4 |
| Quarter ending Mar 31, 2027 | 4 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.8% from $5.38.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $5.53 | $5.39 | $5.39 | $5.38 | $5.38 | +2.9% |
| Fiscal year ending Dec 31, 2027 | $6.01 | $5.99 | $5.99 | $6.00 | $6.00 | +0.2% |
| Quarter ending Mar 31, 2027 | $1.43 | $1.43 | $1.44 | $1.44 | $1.44 | -0.5% |
Frequently Asked Questions About HSIC
What is the HSIC stock forecast?
Consensus analyst estimates put Henry Schein's EPS at $5.53 for the fiscal year ending Dec 31, 2026, on revenue of $13.84B. The consensus rating from 16 analysts is Buy.
How do analysts rate HSIC stock?
Of 16 analysts covering Henry Schein, 4 rate it Strong Buy, 4 Buy, 7 Hold, 1 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from HSIC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $5.53, with estimates from $5.36 to $5.60 from 15 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $6.01, with estimates from $5.88 to $6.18 from 16 analysts.
What revenue do analysts expect from Henry Schein next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $13.84B, with estimates from $13.81B to $13.87B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $14.37B, with estimates from $14.18B to $14.51B.
How many analysts cover HSIC?
16 analysts rate Henry Schein stock, and 15 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
HSIC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts